 In addition, there is continuing research and development of new dual α/δ and γ/δ PPAR agonists for additional therapeutic indications, as well as "pan" agonists acting on all three isoforms.PPARα/γ agonists have shown potential at treating many inflammatory conditions including asthma and eczema.Another emerging avenue of drug research in treating depression and drug addiction is through PPARα and PPARγ activation.